The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...
ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.
Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback